A detailed history of Deka Bank Deutsche Girozentrale transactions in Argenx Se stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 8,445 shares of ARGX stock, worth $5.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,445
Previous 8,445 -0.0%
Holding current value
$5.4 Million
Previous $3.73 Million 19.76%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$356.95 - $413.29 $45,689 - $52,901
128 Added 1.54%
8,445 $3.32 Million
Q4 2023

Jan 24, 2024

SELL
$338.91 - $506.01 $1.33 Million - $1.98 Million
-3,922 Reduced 32.05%
8,317 $3.12 Million
Q2 2023

Jul 25, 2023

BUY
$360.14 - $422.58 $1.63 Million - $1.91 Million
4,524 Added 58.64%
12,239 $4.67 Million
Q3 2022

Nov 02, 2022

SELL
$343.2 - $395.75 $140,712 - $162,257
-410 Reduced 5.05%
7,715 $2.69 Million
Q2 2022

Aug 03, 2022

BUY
$269.58 - $378.88 $731,909 - $1.03 Million
2,715 Added 50.18%
8,125 $2.94 Million
Q1 2022

Apr 28, 2022

BUY
$254.45 - $351.06 $127,225 - $175,530
500 Added 10.18%
5,410 $1.7 Million
Q4 2021

Feb 02, 2022

SELL
$272.01 - $353.03 $12,784 - $16,592
-47 Reduced 0.95%
4,910 $1.69 Million
Q4 2020

Mar 12, 2021

SELL
$248.13 - $308.36 $59,551 - $74,006
-240 Reduced 4.62%
4,957 $1.47 Million
Q3 2020

Oct 29, 2020

BUY
$215.51 - $272.51 $1.12 Million - $1.42 Million
5,197 New
5,197 $1.31 Million
Q3 2019

Nov 14, 2019

SELL
$113.31 - $150.51 $2.04 Million - $2.71 Million
-18,000 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$115.0 - $141.58 $2.53 Million - $3.11 Million
-22,000 Reduced 55.0%
18,000 $2.48 Million
Q1 2019

May 10, 2019

BUY
$98.85 - $134.59 $3.06 Million - $4.17 Million
31,000 Added 344.44%
40,000 $3.75 Million
Q4 2018

Feb 12, 2019

SELL
$63.81 - $109.82 $1.98 Million - $3.4 Million
-31,000 Reduced 77.5%
9,000 $863,000
Q3 2018

Nov 09, 2018

BUY
$75.5 - $96.63 $3.02 Million - $3.87 Million
40,000 New
40,000 $0

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.4B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.